Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
Clinical trial NCT01590277 · COMPLETED
Trial details
- NCT number
- NCT01590277
- Sponsor
- VA Office of Research and Development
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-14
- Primary completion
- 2018-11-02
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.